We are live on ! Find out more
GF

Gates Foundation Portfolio holdings

AUM $43.5M
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
-7.6%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$84.1M
AUM Growth
-$5.76M
Cap. Flow
-$99.4K
Cap. Flow %
-0.12%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CVAC
CureVac
CVAC
+$99.4K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMCR icon
1
Immunocore
IMCR
$1.78B
$37.5M 44.58%
576,923
– –
VIR icon
2
Vir Biotechnology
VIR
$1.48B
$15.8M 18.77%
1,559,142
– –
BNTX icon
3
BioNTech
BNTX
$22.7B
$13.7M 16.3%
148,674
– –
EXAI
4
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$9.1M 10.82%
1,590,909
– –
CVAC
5
DELISTED
CureVac
CVAC
$6.71M 7.98%
1,597,637
-28,306
-2% -$99.4K
BFLY icon
6
Butterfly Network
BFLY
$1.74B
$1.09M 1.3%
1,011,003
– –
LMDX
7
DELISTED
LumiraDx Limited Common Shares
LMDX
$143K 0.17%
14,285,714
– –
BCEL
8
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$73K 0.09%
912,642
– –

Similar funds

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

Gates Foundation's Q1 2024 Portfolio in Review

As of Q1 2024, Gates Foundation held 8 positions worth $84.1M, down 6.4% from $89.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 0%. Gates Foundation opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Gates Foundation's biggest Q1 2024 reduction was CureVac, cutting an estimated $99.4K.
  • Gates Foundation's ten largest holdings make up 100% of its $84.1M portfolio in Q1 2024.
  • Gates Foundation opened 0 new positions and closed 0 in Q1 2024.
  • Gates Foundation's portfolio value fell 6.4% quarter-over-quarter to $84.1M.

Based on Gates Foundation's 13F filing for Q1 2024, filed 14 May 2024.